154 reports of this reaction
1.6% of all TASIMELTEON reports
#14 most reported adverse reaction
POOR QUALITY SLEEP is the #14 most commonly reported adverse reaction for TASIMELTEON, manufactured by Vanda Pharmaceuticals Inc.. There are 154 FDA adverse event reports linking TASIMELTEON to POOR QUALITY SLEEP. This represents approximately 1.6% of all 9,924 adverse event reports for this drug.
Patients taking TASIMELTEON who experience poor quality sleep should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
POOR QUALITY SLEEP is a less commonly reported adverse event for TASIMELTEON, but still significant enough to appear in the safety profile.
In addition to poor quality sleep, the following adverse reactions have been reported for TASIMELTEON:
The following drugs have also been linked to poor quality sleep in FDA adverse event reports:
POOR QUALITY SLEEP has been reported as an adverse event in 154 FDA reports for TASIMELTEON. This does not prove causation, but indicates an association observed in post-market surveillance data.
POOR QUALITY SLEEP accounts for approximately 1.6% of all adverse event reports for TASIMELTEON, making it a notable side effect.
If you experience poor quality sleep while taking TASIMELTEON, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.